上市公司数据是行业发展情况的重要指标。本文根据23家医药流通行业上市公司公开披露的2016年年报资料,分析其收入增长、盈利能力、费用控制、资本运作和战略实施的情况,试图发现一些行业变迁的新动向。
<<The data of listed companies is an important index of industry development. This paper conducts an in-depth study of the 2016 annual data publicly disclosed by 23 listed pharmaceutical circulation companies,by analyzing their income growth,profitability,cost control,capital operation and strategy implementation,in a drive to find the direction of the development and change of Chinese pharmaceutical circulation industry.
<<